Keros Therapeutics, Inc. (KROS): SCHEDULE 13D/A filed Apr 18, 2025

Form type

SCHEDULE 13D/A

Filing date

Apr 18, 2025

Accession number

0001999371-25-004429

Filer

Keros Therapeutics, Inc. (CIK 1664710)